BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 37533431)

  • 1. Case Report: Non-ossifying fibromas with pathologic fractures in a patient with
    Writzl K; Mavčič B; Maver A; Hodžić A; Peterlin B
    Front Genet; 2023; 14():1167054. PubMed ID: 37533431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expanding the genetic and clinical spectrum of the NONO-associated X-linked intellectual disability syndrome.
    Carlston CM; Bleyl SB; Andrews A; Meyers L; Brown S; Bayrak-Toydemir P; Bale JF; Botto LD
    Am J Med Genet A; 2019 May; 179(5):792-796. PubMed ID: 30773818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Further delineation of the phenotypic spectrum associated with hemizygous loss-of-function variants in NONO.
    Sewani M; Nugent K; Blackburn PR; Tarnowski JM; Hernandez-Garcia A; Amiel J; Whalen S; Keren B; Courtin T; Rosenfeld JA; Yang Y; Patterson MC; Pichurin P; McLean SD; Scott DA
    Am J Med Genet A; 2020 Apr; 182(4):652-658. PubMed ID: 31883306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Congenital heart defects and left ventricular non-compaction in males with loss-of-function variants in NONO.
    Scott DA; Hernandez-Garcia A; Azamian MS; Jordan VK; Kim BJ; Starkovich M; Zhang J; Wong LJ; Darilek SA; Breman AM; Yang Y; Lupski JR; Jiwani AK; Das B; Lalani SR; Iglesias AD; Rosenfeld JA; Xia F
    J Med Genet; 2017 Jan; 54(1):47-53. PubMed ID: 27550220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3'UTR Deletion of
    Giuffrida MG; Goldoni M; Genovesi ML; Carpentieri G; Torres B; Deac AD; Cecchetti S; Martinelli A; Vaisfeld A; Flex E; Bernardini L
    Diagnostics (Basel); 2022 Sep; 12(10):. PubMed ID: 36292043
    [No Abstract]   [Full Text] [Related]  

  • 6. Novel hemizygous loss-of-function variant in NONO identified in a South African boy.
    Coetzer KC; Moosa S
    Am J Med Genet A; 2022 Jan; 188(1):373-376. PubMed ID: 34549882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intellectual disability and non-compaction cardiomyopathy with a de novo NONO mutation identified by exome sequencing.
    Reinstein E; Tzur S; Cohen R; Bormans C; Behar DM
    Eur J Hum Genet; 2016 Nov; 24(11):1635-1638. PubMed ID: 27329731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic and phenotypic spectrum in the NONO-associated syndromic disorder.
    Roessler F; Beck AE; Susie B; Tobias B; Begtrup A; Biskup S; Caluseriu O; Delanty N; Fröhlich C; Greally MT; Karnstedt M; Klöckner C; Kurtzberg J; Schubert S; Schulze M; Weidenbach M; Westphal DS; White M; Wolf CM; Zyskind J; Popp B; Strehlow V
    Am J Med Genet A; 2023 Feb; 191(2):469-478. PubMed ID: 36426740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel NONO nonsense variant in a fetus with renal abnormalities.
    Rodriguez-Revenga L; Nadal A; Borobio V; Álvarez-Mora MI; Madrigal I; Pauta M; Borrell A
    Prenat Diagn; 2024 Jan; 44(1):77-80. PubMed ID: 38110236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Case Report: Characterization of a Novel NONO Intronic Mutation in a Fetus With X-Linked Syndromic Mental Retardation-34.
    Sun H; Han L; Zhang X; Hao X; Zhou X; Pan R; Zhang H; He Y
    Front Genet; 2020; 11():593688. PubMed ID: 33304389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. X-linked intellectual developmental disorder with onset of neonatal heart failure: A case report and literature review.
    Xi H; Ma L; Yin X; Yang P; Li X; Li L
    Mol Genet Metab Rep; 2024 Mar; 38():101054. PubMed ID: 38469091
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Saida K; Fukuda T; Scott DA; Sengoku T; Ogata K; Nicosia A; Hernandez-Garcia A; Lalani SR; Azamian MS; Streff H; Liu P; Dai H; Mizuguchi T; Miyatake S; Asahina M; Ogata T; Miyake N; Matsumoto N
    Front Cell Dev Biol; 2021; 9():631428. PubMed ID: 33748114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel NONO variant that causes developmental delay and cardiac phenotypes.
    Itai T; Sugie A; Nitta Y; Maki R; Suzuki T; Shinkai Y; Watanabe Y; Nakano Y; Ichikawa K; Okamoto N; Utsuno Y; Koshimizu E; Fujita A; Hamanaka K; Uchiyama Y; Tsuchida N; Miyake N; Misawa K; Mizuguchi T; Miyatake S; Matsumoto N
    Sci Rep; 2023 Jan; 13(1):975. PubMed ID: 36653413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. De novo missense variants in MEIS2 recapitulate the microdeletion phenotype of cardiac and palate abnormalities, developmental delay, intellectual disability and dysmorphic features.
    Douglas G; Cho MT; Telegrafi A; Winter S; Carmichael J; Zackai EH; Deardorff MA; Harr M; Williams L; Psychogios A; Erwin AL; Grebe T; Retterer K; Juusola J
    Am J Med Genet A; 2018 Sep; 176(9):1845-1851. PubMed ID: 30055086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Locus heterogeneity in two siblings presenting with developmental delay, intellectual disability and autism spectrum disorder.
    Brugger M; Brunet T; Wagner M; Orec LE; Schwaibold EMC; Boy N
    Gene; 2021 Feb; 768():145260. PubMed ID: 33164824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. De novo DDX3X missense variants in males appear viable and contribute to syndromic intellectual disability.
    Nicola P; Blackburn PR; Rasmussen KJ; Bertsch NL; Klee EW; Hasadsri L; Pichurin PN; Rankin J; Raymond FL; ; Clayton-Smith J
    Am J Med Genet A; 2019 Apr; 179(4):570-578. PubMed ID: 30734472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A de novo mutation in the X-linked PAK3 gene is the underlying cause of intellectual disability and macrocephaly in monozygotic twins.
    Hertecant J; Komara M; Nagi A; Al-Zaabi O; Fathallah W; Cui H; Yang Y; Eng CM; Al Sorkhy M; Ghattas MA; Al-Gazali L; Ali BR
    Eur J Med Genet; 2017 Apr; 60(4):212-216. PubMed ID: 28126652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. De novo and inherited TCF20 pathogenic variants are associated with intellectual disability, dysmorphic features, hypotonia, and neurological impairments with similarities to Smith-Magenis syndrome.
    Vetrini F; McKee S; Rosenfeld JA; Suri M; Lewis AM; Nugent KM; Roeder E; Littlejohn RO; Holder S; Zhu W; Alaimo JT; Graham B; Harris JM; Gibson JB; Pastore M; McBride KL; Komara M; Al-Gazali L; Al Shamsi A; Fanning EA; Wierenga KJ; Scott DA; Ben-Neriah Z; Meiner V; Cassuto H; Elpeleg O; Holder JL; Burrage LC; Seaver LH; Van Maldergem L; Mahida S; Soul JS; Marlatt M; Matyakhina L; Vogt J; Gold JA; Park SM; Varghese V; Lampe AK; Kumar A; Lees M; Holder-Espinasse M; McConnell V; Bernhard B; Blair E; Harrison V; ; Muzny DM; Gibbs RA; Elsea SH; Posey JE; Bi W; Lalani S; Xia F; Yang Y; Eng CM; Lupski JR; Liu P
    Genome Med; 2019 Feb; 11(1):12. PubMed ID: 30819258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel MYT1L mutation in a boy with syndromic obesity: Case report and literature review.
    Carvalho LML; D'Angelo CS; Mustacchi Z; da Silva IT; Krepischi ACV; Koiffmann CP; Rosenberg C
    Obes Res Clin Pract; 2021; 15(2):124-132. PubMed ID: 33622623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A de novo PAK1 likely pathogenic variant and a de novo terminal 1q microdeletion in a Chinese girl with global developmental delay, severe intellectual disability, and seizures.
    Zhuang J; Xie M; Yao J; Fu W; Zeng S; Jiang Y; Wang Y; Xie Y; Wang G; Chen C
    BMC Med Genomics; 2023 Jan; 16(1):3. PubMed ID: 36624491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.